ResearchPeptide

AICAR

Published Research

PubMed-indexed studies for AICAR

Research

AICAR, an AMPK activator, protects against cisplatin-induced acute kidney injury through the JAK/STAT/SOCS pathway.

Biochemical and biophysical research communications 2019

View on PubMed →

Research

Lipophagy deficiency exacerbates ectopic lipid accumulation and tubular cells injury in diabetic nephropathy.

Cell death & disease 2021

View on PubMed →

Research

AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity.

Nature 2009

View on PubMed →

Research

AMPK activator AICAR in combination with anti-mouse IL10 mAb restores the functionality of intra-tumoral Tfh cells in the 4T1 mouse model.

Cellular immunology 2022

View on PubMed →

Research

Prior treatment with the AMPK activator AICAR induces subsequently enhanced glucose uptake in isolated skeletal muscles from 24-month-old rats.

Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme 2018

View on PubMed →

Research

AMPK activation attenuates central sensitization in a recurrent nitroglycerin-induced chronic migraine mouse model by promoting microglial M2-type polarization.

The journal of headache and pain 2024

View on PubMed →

Research-Grade AICAR

⚠️ For laboratory research only. Not for human use.

AICAR

Published Research

AICAR, an AMPK activator, protects against cisplatin-induced acute kidney injury through the JAK/STAT/SOCS pathway.

Lipophagy deficiency exacerbates ectopic lipid accumulation and tubular cells injury in diabetic nephropathy.

AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity.

AMPK activator AICAR in combination with anti-mouse IL10 mAb restores the functionality of intra-tumoral Tfh cells in the 4T1 mouse model.

Prior treatment with the AMPK activator AICAR induces subsequently enhanced glucose uptake in isolated skeletal muscles from 24-month-old rats.

AMPK activation attenuates central sensitization in a recurrent nitroglycerin-induced chronic migraine mouse model by promoting microglial M2-type polarization.

Research-Grade AICAR

Frequently Asked Questions

What are research peptides?

What does peptide purity mean and why does it matter?

What form do your peptides come in?

How should research peptides be stored?

Who can purchase research peptides?

How do you ensure peptide quality?

What does "Research Use Only" mean?

How are peptides shipped?

What is your return and refund policy?

Published Research

AICAR, an AMPK activator, protects against cisplatin-induced acute kidney injury through the JAK/STAT/SOCS pathway.

Lipophagy deficiency exacerbates ectopic lipid accumulation and tubular cells injury in diabetic nephropathy.

AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity.

AMPK activator AICAR in combination with anti-mouse IL10 mAb restores the functionality of intra-tumoral Tfh cells in the 4T1 mouse model.

Prior treatment with the AMPK activator AICAR induces subsequently enhanced glucose uptake in isolated skeletal muscles from 24-month-old rats.

AMPK activation attenuates central sensitization in a recurrent nitroglycerin-induced chronic migraine mouse model by promoting microglial M2-type polarization.

Research-Grade AICAR

Frequently Asked Questions

What are research peptides?

What does peptide purity mean and why does it matter?

What form do your peptides come in?

How should research peptides be stored?

Who can purchase research peptides?

How do you ensure peptide quality?

What does "Research Use Only" mean?

How are peptides shipped?

What is your return and refund policy?

⚠️ Research Use Only — Legal Acknowledgment